Eshbal Functional Food Inc. (ESBL) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Eshbal Functional Food Inc. stock C$0.10, price C$0.08, upside +35.0%, quality 57 out of 100. Rating: undervalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range C$0.0500 – C$0.3000 · fair‑value band C$0.0788 – C$0.1238 · the C$0.0750 price screens below the C$0.1013 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Eshbal Functional Food in your weekly email
Every Wednesday you see whether Eshbal Functional Food is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Eshbal Functional Food Inc. research, develops, and manufactures food products and dietary supplements Israel, North America, and Europe.
Show moreShow less
The company manufactures gluten free baked products; and sugar-free products, vegan products, super-foods, dietary supplements, syrups, and dry mixes, including sweeteners and a line of low-carb products under the Eshbal du BARILI free living, Cargil, Confectioner, KOMIDA, and ZEN brand name.
It offers its products through supermarkets, as well as other food retailers, health stores, and foodservice. The company was formerly known as Hakken Capital Corp. and changed its name to Eshbal Functional Food Inc. The company was founded in 1940 and is based in Vancouver, Canada.
Stock analysis
Eshbal Functional Food Inc. (ESBL) currently trades at C$0.0750, while our model-based Fair Value estimate is C$0.1013, implying the stock looks roughly 26% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of C$0.1650 per share, and 19 of the 22 models we run sit above the C$0.0750 price.
Bear case: the Asset-Based group reads lowest at C$0.0300, and 3 of the 22 models stay below the price. Data coverage for this calculation is low.
Scenario range: C$0.0788 (bear) to C$0.1238 (bull), the price of C$0.0750 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Eshbal Functional Food Inc. reported revenue of $11.4M in FY2024 versus $12.1M in FY2022, a compound −2.9%/yr. Reported net income was $313K in FY2024.
Key figures
Market cap C$6.2M (≈ $4.4M) Micro · P/S ratio 0.40 · EPS (TTM) C$−0.0600 · Net margin 2.7% · Return on equity −54.0% · Return on assets (EBIT) 3.9% (3-year average) · Operating margin −23.9% · Revenue (TTM) $15.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 17 out of 100 (low confidence).
What moves the price
The share trades about 64% below its 52-week high and 50% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −1% fair-value upside, at 35%, ESBL screens cheaper than that median.
Fair Value models
BearC$0.0788Fair Value C$0.1013BullC$0.1238
Price C$0.0750 · Upside +35.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−2.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −5.0% a year for the price.
Compare Eshbal Functional Food Inc. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 625 stocks
Beats the industry median on 6/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside+35.1% · Above median
Profitability
Return on assets3.0% · Below median
Net margin (12 months)−11.9% · Bottom 25%
Operating margin (12 months)−23.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)13.9% · Above median
Balance sheet
Debt / equity0.07× · Below median
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/B1.72× · Pricier than median
P/S (12 months)0.28× · Cheapest 25%
Price / free cash flow (fiscal year)8.9× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Eshbal Functional Food Inc. Fair Value". https://www.fairvalue-calculator.com/stock/ESBL
Frequently asked questions
Is Eshbal Functional Food Inc. (ESBL) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of C$0.1013 versus a price of C$0.0750, about +35% upside (undervalued).
What is the fair value of ESBL?
Our model-based fair value for Eshbal Functional Food Inc. is C$0.1013 (as of Nov 8, 2026), built from audited fundamentals. The current price: C$0.0750.
What is the quality score of ESBL?
Eshbal Functional Food Inc. has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Eshbal Functional Food Inc. (ESBL)?
Our model-based price target is the fair value of C$0.1013 (as of Nov 8, 2026) from 22 valuation models. Cautious scenario C$0.0788, optimistic scenario C$0.1238. It is a calculation from audited fundamentals, not an analyst target.
What is the Eshbal Functional Food Inc. stock forecast for 2026?
Our models put fair value at C$0.1013, about +35% upside versus a price of C$0.0750 (undervalued). Cautious scenario C$0.0788, optimistic scenario C$0.1238. The calculation is refreshed regularly with new filings.
What is the revenue of Eshbal Functional Food Inc. (ESBL)?
Eshbal Functional Food Inc. reported trailing-twelve-month revenue of about $15.8M (latest available figure, as of Nov 8, 2026).
What growth is priced into Eshbal Functional Food Inc. (ESBL)?
For today's price to be fair in a discounted-cash-flow model, Eshbal Functional Food Inc. would have to grow free cash flow by -2.8 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew -3.0 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of ESBL use?
Our models discount Eshbal Functional Food Inc. at 8.3 %: a base by market capitalisation (nano), damped by beta 0.11, country premium for Canada. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Eshbal Functional Food Inc. that is -2.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.3 %) and the same formula as our fair value.
How much growth has Eshbal Functional Food Inc. (ESBL) delivered so far?
Over the past 2 years revenue at Eshbal Functional Food Inc. grew -3.0 % a year. The price currently implies free-cash-flow growth of -2.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Eshbal Functional Food Inc. (ESBL) growing?
The median revenue growth in the sector is +2.0 % a year. That is the yardstick for the growth priced into Eshbal Functional Food Inc. (-2.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Eshbal Functional Food Inc. (ESBL)?
The free-cash-flow yield on the price is 13.74 %: that much free cash flow Eshbal Functional Food Inc. produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Eshbal Functional Food Inc. (ESBL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Eshbal Functional Food Inc. it is C$0.1013 per share (as of Nov 8, 2026), against a price of C$0.0750. It is the blended result of 22 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Eshbal Functional Food Inc. stock overvalued or undervalued in 2026?
As of Nov 8, 2026, ESBL trades below its calculated fair value: price C$0.0750, fair value C$0.1013, a gap of about +35% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ESBL?
No. The price is what the market pays today (C$0.0750); the fair value is what the company's own numbers justify (C$0.1013). For Eshbal Functional Food Inc. the two are C$0.0263 per share apart. That gap is exactly why we show both numbers side by side.
How much is Eshbal Functional Food Inc. worth?
The market values Eshbal Functional Food Inc. at about C$6.2M (market capitalisation, as of Nov 8, 2026). Per share that is C$0.0750; our models calculate a fair value of C$0.1013 per share.
What do the bullish and bearish scenarios say about ESBL?
Our models span a range for Eshbal Functional Food Inc.: cautious scenario C$0.0788, base C$0.1013, optimistic C$0.1238 per share (as of Nov 8, 2026, price C$0.0750). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Eshbal Functional Food Inc. (ESBL)?
Balance-sheet figures for Eshbal Functional Food Inc. (as of Nov 8, 2026): return on equity −54.0%, debt of 0.07 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is ESBL from its 52-week high?
Eshbal Functional Food Inc. trades at C$0.0750, about 64% below its 52-week high of C$0.2100 and 50% above the low of C$0.0500 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.1013 is for.
Which stocks are comparable to Eshbal Functional Food Inc.?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Eshbal Functional Food Inc. stock attractive at the current price?
The data as of Nov 8, 2026: price C$0.0750, calculated fair value C$0.1013 (+35%), Quality Score 57/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ESBL calculated?
We run Eshbal Functional Food Inc. through 22 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of C$0.1013 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Eshbal Functional Food Inc. currently trades 26% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Eshbal Functional Food Inc. (ESBL)?
The closing price on Nov 6, 2026 was C$0.0750. Our model-based fair value is C$0.1013, about +35% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Eshbal Functional Food Inc. right now?
The price is below even our cautious bear case (C$0.0788). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (57/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Eshbal Functional Food Inc.
How large is the market capitalisation of Eshbal Functional Food Inc. (ESBL)?
The market capitalisation of Eshbal Functional Food Inc. is C$6.2M (≈ $4.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Eshbal Functional Food Inc. (ESBL)?
The price-to-sales ratio of Eshbal Functional Food Inc. is 0.40 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Eshbal Functional Food Inc. (ESBL)?
Earnings per share at Eshbal Functional Food Inc. are C$−0.0600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Eshbal Functional Food Inc. (ESBL)?
The net margin of Eshbal Functional Food Inc. is 2.7% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Eshbal Functional Food Inc. (ESBL)?
The return on equity (ROE) of Eshbal Functional Food Inc. is −54.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Eshbal Functional Food Inc. (ESBL)?
On an EBIT basis the return on assets of Eshbal Functional Food Inc. is 3.9% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Eshbal Functional Food Inc. (ESBL)?
The operating margin of Eshbal Functional Food Inc. is −23.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Eshbal Functional Food Inc. (ESBL)?
Revenue at Eshbal Functional Food Inc. is growing +13.9% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Eshbal Functional Food Inc. (ESBL)?
Earnings per share at Eshbal Functional Food Inc. are growing −97.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Eshbal Functional Food Inc. (ESBL) carry?
The net debt of Eshbal Functional Food Inc. is $2.5M (fiscal year 2024, ≈ 5.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Eshbal Functional Food Inc. in the live analysis
One click puts Eshbal Functional Food Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 8, 2026